HealthcareServices

Womens Health Diagnostics Market Outlook: Growth and Forecast Highlights 2030

March 4, 2026March 4, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the womens health diagnostics market from 2026–2035 with trusted insights from The Business Research Company

What level of growth is expected in the Womens Health Diagnostics Market between 2026 and 2030?

The womens health diagnostics market has shown strong expansion in recent years. It is anticipated to expand from $36.88 billion in 2025 to $40.38 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.5%. The historical growth experienced by the market can be linked to the increasing occurrence of diseases specific to women, the development of diagnostic infrastructure, heightened awareness about the benefits of early screening, an increase in laboratory testing services, and the adoption of imaging-based diagnostics.

The womens health diagnostics market is projected to experience substantial expansion over the coming years. Its valuation is anticipated to reach $59.02 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.0%. This projected growth is driven by factors such as a heightened demand for personalized diagnostic solutions, increasing capital directed towards precision testing innovations, the proliferation of home-based diagnostic methods, the expanding incorporation of AI analytics, and a greater emphasis on preventive screening initiatives. Key trends anticipated during this period encompass the wider embrace of advanced imaging and testing methodologies, the growing utilization of at-home diagnostic kits, the increasing application of AI in interpreting diagnostic results, the broadening scope of genetic and hormonal testing, and an intensified concentration on the early detection of diseases.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10725&type=smp

Which Drivers Are Expected To Impact The Womens Health Diagnostics Market During The Forecast Period?

The increasing need for personalized medicine is projected to drive the expansion of the women’s health diagnostics market in the future. This approach to medicine involves treatments that prevent, identify, or address illnesses by leveraging an individual’s specific genetic makeup or proteins. It enables healthcare professionals to formulate treatment strategies precisely adapted to a woman’s distinct genetic, molecular, and clinical characteristics. Such strategies may include targeted therapies founded on genetic markers or particular biomarkers. As an illustration, in February 2024, data from the Personalized Medicine Coalition (PMC), a US-based nonprofit research organization, revealed that the US Food and Drug Administration sanctioned 16 new personalized treatments for rare disease patients in 2023, an increase from 6 approvals in 2022. The 2023 approvals also included seven oncology therapies and three treatments addressing various other conditions. Consequently, the rising demand for personalized medicine is fueling the growth of the women’s health diagnostics market.

Which Segments Are Driving Activity In The Womens Health Diagnostics Market?

The womens health diagnostics market covered in this report is segmented –

1) By Type: Accessories And Consumables, Diagnostic Tests, Diagnostic Devices

2) By Application: Osteoporosis Testing, Ovarian Cancer Testing (OVC), Cervical Cancer Testing, Breast Cancer Testing, Pregnancy And Fertility Testing, Prenatal Genetic Screening And Carrier Testing, Infectious Disease Testing, Sexually Transmitted Diseases (STD) Testing, Ultrasound Tests

3) By End User: Hospitals And Clinics, Diagnostic And Imaging Centers, Homecare, Other End Users

Subsegments:

1) By Accessories And Consumables: Test Kits, Sample Collection Devices, Reagents, Control Materials

2) By Diagnostic Tests: Blood Tests, Imaging Tests, Genetic Tests, Hormonal Tests

3) By Diagnostic Devices: Imaging Devices, Invasive Diagnostic Devices, Non-Invasive Diagnostic Devices, Monitoring Devices

Which Competitive Trends Are Impacting The Structure Of The Womens Health Diagnostics Market?

Leading companies operating in the women’s health diagnostics market are prioritizing product innovations, such as advanced ultrasound systems, to secure their market position. A premium ultrasound system refers to a sophisticated and cutting-edge medical imaging device engineered to capture precise and high-quality images of internal body structures. This type of ultrasound system is part of Samsung’s HERA platform, which is specifically designed for obstetrics and gynecology. For instance, in February 2023, Samsung’s digital radiography and ultrasound business, a US-based company, launched the HERA W10 Elite, a state-of-the-art women’s health ultrasound system. It is equipped with a range of artificial intelligence (AI) tools and clinical applications, marking a significant improvement in the diagnostic experience for women’s health. The HERA W10 Elite includes advanced features such as MV-Flow for displaying blood flow intensity, BiometryAssist for convenient measurement of fetal growth parameters, and accurate analytic capabilities to aid clinicians in their diagnosis.

Which Major Industry Participants Are Leading The Womens Health Diagnostics Market Growth?

Major companies operating in the womens health diagnostics market are Becton Dickinson And Company, F. Hoffmann-La Roche AG, General Electric Company, Koninklijke Philips N.V., Quest Diagnostics Incorporated, Siemens Healthineers, Abbott Laboratories, BioMérieux SA, Hologic Inc., PerkinElmer Inc., Alere Inc., Carestream Health Inc., Procter & Gamble Co., Trinity Biotech plc, Medgyn Products Inc., URIT Medical Electronic Co. Ltd, Sonic Healthcare Limited, Fujifilm Holdings Corporation, Thermo Fisher Scientific Inc., Illumina Inc., Myriad Genetics Inc., Agilent Technologies Inc., Bio-Rad Laboratories Inc., Danaher Corporation, Genomic Health Inc., Invitae Corporation, Natera Inc., QIAGEN N.V., Opko Health Inc., Sysmex Corporation, Exact Sciences Corporation, Foundation Medicine Inc., Laboratory Corporation of America Holdings, NeoGenomics Laboratories Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/womens-health-diagnostics-global-market-report

Which Region Is Expected To Experience The Fastest Growth In The Womens Health Diagnostics Market?

North America was the largest region in the women’s health diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global women’s health diagnostics market report during the forecast period. The regions covered in the womens health diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Womens Health Diagnostics Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=10725&type=smp

Browse Through More Reports Similar to the Global Womens Health Diagnostics Market 2026, By The Business Research Company

Womens Health Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/womens-health-devices-global-market-report

Womens Health Market Report 2026

https://www.thebusinessresearchcompany.com/report/womens-health-global-market-report

Clinical Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/clinical-diagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795